Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: James Silverman who wrote (111)	11/11/1997 11:38:00 PM
From: Uncle Mikey	Respond to of 340

Hey Jay watta ya know? I was just talking to you on the ECILF thread. I looked at a longterm (6 year chart) of Teva last night. Take a look. The trend is always up but every year it has climbed in a big "wave", with a major up and down cycle each year. You know, you are probably right about the Teva/PR thing. Non-US companies don't play the PR/IR game the same way. I suppose you read the article in Globes about Teva? The explanation there re Coxapane was something to the effect that "the difference between disappointment and satisfaction (in the number of patients using the drug) is very small at this point" and they did not want to make a mistake by releasing number prematurely. I sold a teeny bit of Teva yesterday because I have made so much in cap gains this year that I decided it would be nice (in a sick sort of way) to have something negative in the "sold" column to help with taxes. I spent the proceeds in Brazil. (Telebras)